Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis.

Saved in:
Bibliographic Details
Title: Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis.
Authors: Wang C; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., LaBere BA; Division of Allergy and Immunology, Phoenix Children's, Phoenix, Arizona, USA., Chinga MML; Division of Allergy and Immunology, Phoenix Children's, Phoenix, Arizona, USA., Harris AJ; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Rosen LB; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Rivera AE; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Le Run E; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Sacco KA; Immunology Department, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom., Ballan W; Division of Infectious Diseases, Phoenix Children's, Phoenix, Arizona, USA., Woodward JV; Division of Pulmonology, Phoenix Children's, Phoenix, Arizona, USA., Ostdiek SA; Division of Infectious Diseases, Phoenix Children's, Phoenix, Arizona, USA., Smith MW; Division of Infectious Diseases, Phoenix Children's, Phoenix, Arizona, USA., Anderson VL; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Daub JR; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Palmer CL; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kluczynski LC; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Oler AJ; Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Walkiewicz MA; Centralized Sequencing Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ghosh R; Centralized Sequencing Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Similuk M; Centralized Sequencing Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Donovan FM; Valley Fever Center for Excellence, College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.; Department of Medicine, College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.; Department of Immunobiology, College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.; BIO5 Institute, University of Arizona, Tucson, Arizona, USA., Witt J; MiraVista Diagnostics, Indianapolis, Indiana, USA., Barros N; MiraVista Diagnostics, Indianapolis, Indiana, USA.; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA., Wheat LJ; MiraVista Diagnostics, Indianapolis, Indiana, USA., Galgiani JN; Valley Fever Center for Excellence, College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.; Department of Medicine, College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.; Department of Immunobiology, College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.; BIO5 Institute, University of Arizona, Tucson, Arizona, USA., Freeman AF; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Hsu AP; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Zerbe CS; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Holland SM; Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 04; Vol. 81 (6), pp. e544-e547.
Publication Type: Journal Article; Review; Research Support, N.I.H., Intramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/ciaf286